Segui
María José Acuña Díaz-Tendero
María José Acuña Díaz-Tendero
Directora de Investigación y Doctorados, Universidad Bernardo O`Higgins
Email verificata su ubo.cl
Titolo
Citata da
Citata da
Anno
Restoration of muscle strength in dystrophic muscle by angiotensin-1-7 through inhibition of TGF-β signalling
MJ Acuña, P Pessina, H Olguin, D Cabrera, CP Vio, M Bader, ...
Human molecular genetics 23 (5), 1237-1249, 2014
1742014
Angiotensin II-induced pro-fibrotic effects require p38MAPK activity and transforming growth factor beta 1 expression in skeletal muscle cells
MG Morales, Y Vazquez, MJ Acuña, JC Rivera, F Simon, JD Salas, JÁ Ruf, ...
The international journal of biochemistry & cell biology 44 (11), 1993-2002, 2012
982012
Angiotensin-(1-7) attenuates disuse skeletal muscle atrophy in mice via its receptor, Mas
MG Morales, J Abrigo, MJ Acuña, RA Santos, M Bader, E Brandan, ...
Disease models & mechanisms 9 (4), 441-449, 2016
792016
The internal region leucine-rich repeat 6 of decorin interacts with low density lipoprotein receptor-related protein-1, modulates transforming growth factor (TGF)-β-dependent …
C Cabello-Verrugio, C Santander, C Cofré, MJ Acuña, F Melo, E Brandan
Journal of Biological Chemistry 287 (9), 6773-6787, 2012
762012
Fibrotic response induced by angiotensin-II requires NAD (P) H oxidase-induced reactive oxygen species (ROS) in skeletal muscle cells
C Cabello-Verrugio, MJ Acuña, MG Morales, A Becerra, F Simon, ...
Biochemical and biophysical research communications 410 (3), 665-670, 2011
762011
ACE2 is augmented in dystrophic skeletal muscle and plays a role in decreasing associated fibrosis
C Riquelme, MJ Acuña, J Torrejón, D Rebolledo, D Cabrera, RA Santos, ...
PloS one 9 (4), e93449, 2014
702014
The anti-adipogenic effect of angiotensin II on human preadipose cells involves ERK1, 2 activation and PPARG phosphorylation
P Fuentes, MJ Acuña, M Cifuentes, CV Rojas
Journal of Endocrinology 206 (1), 75, 2010
582010
The pro-fibrotic connective tissue growth factor (CTGF/CCN2) correlates with the number of necrotic-regenerative foci in dystrophic muscle
MG Morales, MJ Acuña, D Cabrera, R Goldschmeding, E Brandan
Journal of Cell Communication and Signaling 12, 413-421, 2018
472018
HIF-hypoxia signaling in skeletal muscle physiology and fibrosis
R Valle-Tenney, D Rebolledo, MJ Acuña, E Brandan
Journal of cell communication and signaling 14 (2), 147-158, 2020
422020
Larger anti‐adipogenic effect of angiotensin II on omental preadipose cells of obese humans
R Brücher, M Cifuentes, MJ Acuña, C Albala, CV Rojas
Obesity 15 (7), 1643-1646, 2007
412007
Transforming growth factor type beta 1 increases the expression of angiotensin II receptor type 2 by a SMAD‐and p38 MAPK‐dependent mechanism in skeletal muscle
P Painemal, MJ Acuña, C Riquelme, E Brandan, C Cabello‐Verrugio
Biofactors 39 (4), 467-475, 2013
362013
Blockade of Bradykinin receptors worsens the dystrophic phenotype of mdx mice: differential effects for B1 and B2 receptors
MJ Acuña, D Salas, A Córdova-Casanova, M Cruz-Soca, C Céspedes, ...
Journal of Cell Communication and Signaling 12, 589-601, 2018
212018
The functional and molecular effects of problematic alcohol consumption on skeletal muscle: A focus on athletic performance
C Caceres-Ayala, RM Pautassi, MJ Acuña, W Cerpa, DL Rebolledo
The American Journal of Drug and Alcohol Abuse 48 (2), 133-147, 2022
152022
Proliferation and differentiation of human adipocyte precursor cells: differences between the preperitoneal and subcutaneous compartments
M Fernández, MJ Acuna, M Reyes, D Olivares, S Hirsch, D Bunout, ...
Journal of cellular biochemistry 111 (3), 659-664, 2010
152010
Role of matricellular CCN proteins in skeletal muscle: focus on CCN2/CTGF and its regulation by vasoactive peptides
DL Rebolledo, MJ Acuña, E Brandan
International Journal of Molecular Sciences 22 (10), 5234, 2021
122021
Transforming growth factor type‐β inhibits Mas receptor expression in fibroblasts but not in myoblasts or differentiated myotubes; Relevance to fibrosis associated to muscular …
C Cofre, MJ Acuña, O Contreras, MG Morales, C Riquelme, ...
Biofactors 41 (2), 111-120, 2015
102015
ESICM LIVES 2016: part three: Milan, Italy. 1–5 October 2016
T Velasquez, G Mackey, J Lusk, UG Kyle, T Fontenot, P Marshall, ...
Intensive Care Medicine Experimental 4, 405-607, 2016
82016
Analysis of pathological activities of CCN2/CTGF in muscle dystrophy
MJ Acuña, E Brandan
CCN Proteins: Methods and Protocols, 513-521, 2017
52017
Episodic binge-like ethanol reduces skeletal muscle strength associated with atrophy, fibrosis, and inflammation in young rats
C Cáceres-Ayala, RG Mira, MJ Acuña, E Brandan, W Cerpa, ...
International Journal of Molecular Sciences 24 (2), 1655, 2023
42023
Skeletal muscle system
MJ Acuña, E Brandan, D Motta-Santos
Angiotensin-(1-7) A Comprehensive Review, 169-190, 2019
22019
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20